Brind.

Roivant filed a 10-Q statement with the SEC on August 12, 2025, while its stock was sliding against a marginally down S&P 500.

2 reports, 2 independent Updated Aug 12
Gone quiet Reached 2 outlets in its first 24 hours
Reports
2
Developments
2
Repetition
0%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Roivant filed a 10-Q statement with the SEC on August 12, 2025, while its stock was sliding against a marginally down S&P 500.

Who's involved

What this event is mainly about
Roivant Sciences (United States)S&P

How it developed

Newest first. Tap a step to see who reported it.
  1. Roivant filed a 10-Q with the SEC on August 12, 2025, amidst stock movement.1 source
  2. Roivant's quarterly financial performance discussion included the Montes Archimedes Acquisition.1 source

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • Motley FoolWhy Roivant Sciences Stock Was Slipping on Monday The biotech published an earnings report that fell short of expectations. It whiffed on both the top and bottom lines. 10 stocks we like better than
  • ZacksRoivant Sciences Ltd. (ROIV) Reports Q1 Loss, Misses Revenue Estimates Roivant Sciences Ltd. (ROIV) came out with a quarterly loss of $0.18 per share versus the Zacks Consensus Estimate of a loss of